Navigation Links
ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration
Date:7/29/2009

esized mechanism of Homspera's immune system activation, and expands the therapeutic range over which activity of the compound has been shown in accepted animal models. Perhaps just as important is the demonstration that oral administration of Homspera results in therapeutic effects. This suggests appropriate oral formulations could provide convenient, efficacious immune system augmentation in a number of medical (e.g., cancer therapy, vaccine adjuvancy) and homeland security-related scenarios (e.g., CBRN threats, including unique and/or weaponized microbiological and viral agents).

About ImmuneRegen BioSciences Inc.

ImmuneRegen BioSciences Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTC BB: IRBS), is a development-stage biotechnology company engaged in the research, development and licensing of the potential drug candidate Homspera and its derivatives Radilex(R) and Viprovex(R). Management is focused on the development of these drug candidates as potential treatments for blood disorders and to accelerate wound healing. Findings to date suggest additional opportunities for these compounds as a vaccine adjuvant and potential treatment for influenza or other microbial ailments, as well as for use as a possible countermeasure for homeland security threats including radiological, chemical and biological agents. For more information, visit www.immuneregen.com.

Statements about ImmuneRegen's future expectations, including statements about the potential use and scientific results for ImmuneRegen's drug candidates, science and technology, and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigatio
'/>"/>

SOURCE ImmuneRegen BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
2. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
3. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
9. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... simple, cheap, accurate test to find undetected landmines. , ... custom-made bacteria that glows green when it comes into ... bacteria can be mixed into a colourless solution that, ... to indicate the presence of landmines. , Researchers ... could be delivered from the air onto areas thought ...
(Date:12/16/2009)... death from roadside bombs to freeway crashes. Traumatic injury, ... to 44, often overwhelms the body,s natural blood-clotting process. ... a team led by Erin Lavik, a new Case ... doctoral student, James P. Bertram, built synthetic platelets that ... work is published in Science Translational Medicine ., ...
(Date:12/16/2009)... Calif., Dec. 16 WaferGen Biosystems, Inc. ... state-of-the-art genetic analysis systems, today announced that it ... its innovative service for gene-expression profiling using its ... Panel provides the most comprehensive human microRNA panel ... The company,s SmartChip service offers customers the use ...
(Date:12/16/2009)... Cord Blood America, Inc. (OTC Bulletin ... preservation company ( http://www.cordblood-america.com ) focused on ... a biological insurance policy, to families nationwide and ... debt by a total of $1.4 million so ... total debt eliminated for the year now tops ...
Breaking Biology Technology:Researchers take the inside route to halt bleeding 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3
... Scheduled for Monday, October 6, 2008 at ... 2 ARCA biopharma, Inc., a,biopharmaceutical company ... cardiovascular diseases, today announced that,Richard Brewer, the ... Michael Bristow, M.D., ARCA,s chairman and chief ...
... Approval would make Zevalin only Radioimmunotherapy in U.S. to be ... ... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) announced today ... the U.S. Food and Drug,Administration (FDA) for use of Zevalin(R) ...
... - Announcement No. 40/2008, - To OMX Nordic ... announces a grant of license to Roche Diagnostics for,use ... proprietary,LNA(TM) detection technology., Roche Diagnostics will develop its ... Universal ProbeLibrary that is based on Exiqon,s,proprietary LNA(TM) detection ...
Other Biology Technology:ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 2ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 3ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 4ARCA biopharma to Present at JMP Securities Healthcare Focus Conference 5Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 2Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 3Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 4Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 5Exiqon A/S Today Announces a Grant of License to Roche Diagnostics 2Exiqon A/S Today Announces a Grant of License to Roche Diagnostics 3
(Date:12/16/2009)... Knowledge and Innovation Community (Climate-KIC)" is a major initiative ... program brings together the expertise of world class partners ... Europe,s innovation capacity to meet the climate change challenge ... a new low-carbon society. In responding to this challenge, ... produce, distribute, and consume goods, and to how we ...
(Date:12/16/2009)... US Secretary of Energy Steven Chu announced today the ... outstanding contributions in research and development supporting the Department ... named today will receive a gold medal, a citation ... a ceremony in Washington, DC early next year., "The ... economic and energy security of the United States are ...
(Date:12/16/2009)... of financial and technical assistance to developing countries around ... to be connected to space technology, but large development ... linked. , Global climate change is also an increasingly ... the poorest countries and communities, which will suffer the ... to a growing demand for information about the state ...
Breaking Biology News(10 mins):Innovation boost to tackle climate change 2Innovation boost to tackle climate change 3Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2ESA and World Bank move toward closer collaboration 2ESA and World Bank move toward closer collaboration 3ESA and World Bank move toward closer collaboration 4Forsyth scientists suggest linkages between obesity and oral bacterial infection 9176 1Forsyth scientists suggest linkages between obesity and oral bacterial infection 9176 2The Hispanic got milk 3F Campaign Visits Chicago from July 2 July 10 51122 1The Hispanic got milk 3F Campaign Visits Chicago from July 2 July 10 51122 2Advanced Heart Procedure Treats Growing Problem 51120 1Advanced Heart Procedure Treats Growing Problem 51120 2Advanced Heart Procedure Treats Growing Problem 51120 3
... whale and its large prey, the jumbo squid, are ... depths of 3,000 feet or more. Now, in a ... successful tagging of sperm whales and jumbo squid swimming ... tracking devices have been applied simultaneously to deep-diving predators ...
... cells from the lungs of transplant patients demonstrates for the ... and are not derived from bone marrow, which leads to ... with the rejection of donated organs and with various kinds ... Michigan Health System researchers is significant because of the large ...
... January issue of the journal Cell Metabolism, published by Cell ... formation of a poorly understood type of muscle. Moreover, they ... fibers were able to run farther and at higher work ... lead to novel drugs designed to change the composition of ...
Other Biology News:Tracking sperm whales and jumbo squid 2Tracking sperm whales and jumbo squid 3Tracking sperm whales and jumbo squid 4Tracking sperm whales and jumbo squid 5Tracking sperm whales and jumbo squid 6Type of stem cell found to reside in transplanted lungs 2Type of stem cell found to reside in transplanted lungs 3'Marathon mice' elucidate little-known muscle type 2'Marathon mice' elucidate little-known muscle type 3
... Ciphergen's ProteinChip arrays have been developed ... biological samples. A variety of ProteinChip ... proteins according to their unique biochemical ... spots, allowing side-by-side sample comparison, and ...
Thermal printer paper is used with the thermal printer for the VersaFluor fluorometry systems. Supplied as 10 rolls....
The thermal printer, 120 V, is used to record fluorescence data acquired with the VersaFluor fluorometry systems. The printer includes a cable and power adaptor....
... SR-101 Labeled Substrates (red fluorescence; Ex=590 ... serine protease activation • No lysing, ... Kits utilize cell-permeable, fluorescently labeled inhibitors ... chymotrypsin-like activity in whole living cells. ...
Biology Products: